Skip To Main Content
ROBERT STEELE on Muck Rack

ROBERT STEELE

As seen in: Nature, Wiley Online Library, EIN News, BiggerPockets, The Journal of Biological Chemistry, Modern Casting, Workday Blog

Get in touch with ROBERT

Contact ROBERT, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

Author Correction: Colonoscopy and fecal immunochemical testing versus usual care in diagnostic colorectal cancer screening: the SCREESCO randomized controlled trial

|
By Marcus Westerberg, Jonas Ludvigsson, Chris Metcalfe, Ulf Strömberg, Johannes Blom, Lars Engstrand, Mikael Hellström, Christian Löwbeer, ROBERT STEELE, Lars Holmberg, Anna Forsberg
| Nature Verified
Correction to: Nature Medicine https://doi.org/10.1038/s41591-026-04225-9, published online 20 February 2026.
Open in Who Shared Issue with article?

LLM-assisted systematic review of large language models in clinical medicine - Nature Medicine

|
By Sully Chen, Anton Alyakin, Andreas Seas, Eunice Yang, Joanne Choi, Jin Lee, Amelia Chen, Pranav Warman, ROBERT STEELE, Daniel Alber, Eric K. Oermann, Rochelle T. Bitolas
| Nature Verified
Abstract Clinical evaluations of large language models (LLMs) have rapidly expanded since 2022, yet their evidence base remains opaque. The overwhelming volume of studies creates challenges for manual curation and review. However, LLMs themselves offer the scalability and capability to evaluate the ever-growing evidence base. This LLM-assisted review identified 4,609 peer-reviewed studies in clinical medicine between January 2022 and September 2025, equating to roughly 3.2 papers per day.
Open in Who Shared Issue with article?

Colonoscopy and fecal immunochemical testing versus usual care in diagnostic colorectal cancer screening: the SCREESCO randomized controlled trial - Nature Medicine

|
By Marcus Westerberg, Jonas Ludvigsson, Chris Metcalfe, Ulf Strömberg, Johannes Blom, Lars Engstrand, Mikael Hellström, Christian Löwbeer, ROBERT STEELE, Lars Holmberg, Anna Forsberg
| Nature Verified
Abstract There is a need to quantify the benefits and harms of colorectal cancer (CRC) screening using primary colonoscopy or fecal immunochemical testing (FIT) compared with usual care with no screening. Guidelines recommend screening in individuals aged 50–75 years using colonoscopy or FIT, and many screening programs use one-sample biennial FIT.
Open in Who Shared Issue with article?
See all 16 articles